Upcoming IPOs: 10 Issues Opening Next Week as GMP Signals Strong Listing Gains

The Indian IPO market is set for another busy week, with 10 public issues scheduled around the August 24–31 period across the mainboard and SME segments. The combined issue size is expected to exceed ₹3,300 crore, with Symbiotec Pharmalab and Skyways Air Services among the prominent offerings.

According to the GMP figures provided, Symbiotec Pharmalab has the highest grey market premium at ₹345, while several other issues are currently showing little or no GMP.

Which IPOs Are Coming Next Week?

The list includes companies from pharmaceuticals, engineering, healthcare, logistics, infrastructure and other sectors. The issues mentioned are:

IPO                                           Segment                GMP

Symbiotec Pharmalab Ltd.          Mainboard        ₹345

Madhur Knit Crafts Ltd.               SME                  ₹0

Hi-Tech Engineers Ltd.           Mainboard         ₹22

ABH Healthcare Ltd.                      SME                  ₹0

Skyways Air Services Ltd.            Mainboard         ₹42

Sumax Engineering Ltd.              SME                 ₹30

Annu Projects Ltd.                    Mainboard          ₹4

Quick Forensic Solutions Ltd.       SME                  ₹0

Lumino Industries Ltd.             Mainboard         ₹46

Complete Sports and Management India   SME          ₹0

Recent market coverage confirms that Symbiotec Pharmalab's IPO opened on August 24 with a ₹1,757-crore issue, while Madhur Knit Crafts and ABH Healthcare are among the SME offerings opening during the week.

Symbiotec Pharmalab Has the Highest GMP

Among the IPOs listed above, Symbiotec Pharmalab's ₹345 GMP is the highest. Its IPO has a price band of ₹938–₹988 per share and is scheduled to remain open from August 24 to August 27.

The company operates in the pharmaceutical and biotechnology space, with products including active pharmaceutical ingredients and specialty products. More than two-thirds of its revenue comes from international markets, according to recent market analysis.

The company also received ₹526.20 crore in anchor investment ahead of the public issue, with investors including Citi Group and Singularity.

What Does the GMP Indicate?

Grey Market Premium (GMP) reflects the unofficial premium at which an IPO's shares are reportedly being traded in the grey market before listing.

A high GMP can indicate strong unofficial demand, but it does not guarantee a listing gain. GMP can change rapidly depending on market sentiment, subscription levels and broader market conditions.

Therefore, investors should not apply for an IPO solely because its GMP is high. The company's valuation, financial performance, business model, risks and IPO price should also be examined.

IPO Investors Should Keep These Points in Mind

The upcoming IPO calendar offers several opportunities, but the issues span different sectors and risk profiles. Mainboard and SME IPOs also have different listing and trading characteristics.

Investors should therefore check the official offer documents, price band, subscription data and company fundamentals before making an investment decision.